NCT06849895

Brief Summary

This prospective, school-based cohort study aims to enroll approximately 15,000 primary school students from multiple districts in Shanghai, China and to observe the outcomes on myopia prevention and control in children with varying refractive status (including sufficient hyperopia reserve, relative insufficiency in hyperopia reserve, pre-myopia and myopia) who are exposed to a school-based categorized and integrated interventions strategy in real-world settings. The primary objective of this study is to observe the change in the incidence and prevalence of myopia as well as the the progression of myopia among primary school students population under a school-based interventions, including increasing outdoor activities and wearing special designed optical lenses. The second objective is to identify factors influencing the outcomes and assess the compliance of different intervention methods. Additionally, a cost-effectiveness analysis will be conducted to assess the implementation process, providing technical solutions and operational models for wider application.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15,000

participants targeted

Target at P75+ for all trials

Timeline
23mo left

Started Feb 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Feb 2025Feb 2028

First Submitted

Initial submission to the registry

February 13, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 27, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

February 28, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2028

Last Updated

February 27, 2025

Status Verified

February 1, 2025

Enrollment Period

3 years

First QC Date

February 13, 2025

Last Update Submit

February 23, 2025

Conditions

Keywords

myopiapremyopiaoutdoor activitiesmyopia preventionmyopia controlchildrencompliancedefocus optical lenses

Outcome Measures

Primary Outcomes (2)

  • Myopia incidence

    Myopia incidence

    Assessed at 12 months, 24 months, and 36 months post-baseline.

  • Myopia progression

    Myopia progression in myopic participants

    Assessed at 12 months, 24 months, and 36 months post-baseline.

Secondary Outcomes (1)

  • Myopic shift

    Assessed at 12 months, 24 months, and 36 months post-baseline.

Study Arms (4)

Sufficient hyperopia reserve

Cycloplegic spherical equivalence is higher than the recommended values and falls within the normal range for the corresponding age group.

Relative insufficiency in hyperopia reserve

Cycloplegic spherical equivalence is greater than +0.75 diopters but below the recommended value for the corresponding age group.

Premyopia

-0.50 diopters \< cycloplegic spherical equivalence ≤ +0.75 diopters

Myopia

Cycloplegic spherical equivalence ≤ -0.50 diopters

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All students in the enrolled schools can participate in the project and receive tiered interventions after obtaining informed consent from their guardians. After professional examination, students with conditions such as strabismus, amblyopia, other significant ocular abnormalities, systemic diseases, or those currently undergoing other myopia interventions will generally not be fitted with specially designed myopia control spectacles.

You may qualify if:

  • All students from the enrolled schools;
  • Participants must be able to cooperate with and complete all required ophthalmic examinations;
  • Written informed consent must be obtained from their parents or legal guardians.

You may not qualify if:

  • Ocular abnormalities (e.g., strabismus, amblyopia, or other significant eye diseases);
  • Systemic diseases that may affect ocular health;
  • Current participation in other myopia intervention programs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Eye Disease Prevention and Treatment Center

Shanghai, Shanghai Municipality, 200336, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

Saliva

MeSH Terms

Conditions

MyopiaRefractive ErrorsPatient Compliance

Condition Hierarchy (Ancestors)

Eye DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Central Study Contacts

Xiangui He, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2025

First Posted

February 27, 2025

Study Start

February 28, 2025

Primary Completion (Estimated)

February 28, 2028

Study Completion (Estimated)

February 28, 2028

Last Updated

February 27, 2025

Record last verified: 2025-02

Locations